Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
181
Frequently Asked Questions
What is Market Cap of Fate Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Fate Therapeutics Inc market cap is $116.48M.
What is the 52-week high for Fate Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Fate Therapeutics Inc 52 week high is $4.20 as of September 09, 2025.
What is the 52-week low for Fate Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Fate Therapeutics Inc 52 week low is $0.661 as of September 09, 2025.
What is Fate Therapeutics Inc stock price today?
Fate Therapeutics Inc stock price today is $0.966.
What was Fate Therapeutics Inc stock price yesterday?
Fate Therapeutics Inc stock price yesterday was $1.01.
What is the PE ratio of Fate Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Fate Therapeutics Inc’s P/E ratio is -0.70.
What is the Price-to-Book ratio of Fate Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Fate Therapeutics Inc P/B ratio is 0.4431.
What is the 50-day moving average of Fate Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Fate Therapeutics Inc 50-day moving average is $1.11.
How many employess does Fate Therapeutics Inc has?